• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NASH

Recent news which mentions NASH

VettaFi Voices On: One Year as VettaFi
May 19, 2023
Tags VettaFi exchange an etf experience Exchange ETFs
From ETF Trends
CBG: The 'Mother Cannabinoid' May Hold Key To Treating Nonalcoholic Fatty Liver Disease Symptoms
January 23, 2023
Tickers CBG
Tags Benzinga nonalcoholic fatty liver disease Shelby McDaniel
From Benzinga
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
August 25, 2021
Tickers LPCN
Tags Trading Ideas Briefs Phase 2 Trial
From Benzinga
CohBar Stock Edges Higher As Mitochondria Based Therapeutic Shows Encouraging Action In Early-Stage NASH Trial
August 11, 2021
Tickers CWBR
Tags Biotech Benzinga NASH
From Benzinga
Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial
August 02, 2021
Tickers GLMD
Tags Briefs General News
From Benzinga
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
July 15, 2021
Tickers THTX
Tags Phase 3 Trial Penny Stocks News
From Benzinga
CohBar Stock Slumps As Data From NASH, Obesity Candidate Delayed By Almost Two Months
July 14, 2021
Tickers CWBR
Tags Biotech Benzinga Briefs
From Benzinga
Hepion Pharma's NASH Candidate Aces Mid-Stage Study
July 13, 2021
Tickers HEPA
Tags General News Penny Stocks
From Benzinga
Akero's NASH Candidate Shows Substantial Liver Fat Reductions After Four Months Of Treatment
July 08, 2021
Tickers AKRO
Tags Briefs Benzinga Biotech
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap